WeVote
Log In

Bill

Bill

S 6851

Authorizes physicians and pharmacists to enter into collaborative practice medication adherence protocols for their patients

2025 Regular Session Introduced by Lea Webb

Summary of S 6851: Medication Adherence Protocols Bill OverviewThis bill, S 6851, authorizes physicians and pharmacists to enter into collaborative practice agreements that establi

REFERRED TO HIGHER EDUCATION
0
WeVote Research Nonpartisan
Bill Summary · S 6851

Summary of S 6851: Medication Adherence Protocols

Bill Overview

This bill, S 6851, authorizes physicians and pharmacists to enter into collaborative practice agreements that establish medication adherence protocols for their patients. The goal is to improve patient outcomes by allowing pharmacists to take a more active role in monitoring and supporting medication adherence.

Key Provisions

  • Permits physicians and pharmacists to voluntarily enter into written collaborative practice agreements.
  • Under these agreements, pharmacists would be authorized to:
    • Adjust medication dosages or formulations within specified parameters.
    • Order and interpret laboratory tests related to the managed medications.
    • Provide medication management services, including monitoring patient adherence.
  • Specifies training and oversight requirements for pharmacists participating in these collaborations.
  • Requires the state pharmacy board to develop regulations governing the collaborative practice agreements.

Impact and Affected Parties

  • This bill aims to improve medication adherence and health outcomes for patients by leveraging the expertise of pharmacists.
  • It would primarily affect:
    • Patients who opt to participate in these collaborative practice protocols with their physician and pharmacist.
    • Healthcare providers, including physicians and pharmacists, who choose to establish these collaborative agreements.
    • The state pharmacy board, which would be responsible for establishing the regulatory framework.
  • Improved medication adherence could lead to reduced hospitalizations, fewer adverse drug events, and better overall health for participating patients.

Procedural Timeline

  • The bill was introduced in the state legislature on March 25, 2025.
  • It has been referred to the Higher Education committee for further consideration.
  • If passed by the legislature and signed into law, the state pharmacy board would have 6 months to develop the necessary regulations.
  • The collaborative practice agreements could then be implemented once the regulatory framework is in place.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.